07 September 2020 | News
Lianhua Qingwen capsules - as a herbal medicine to be registered in Kuwait
Image source: Yiling Pharma
China-based Yiling Pharmaceutical recently issued a notice that it had received a certificate of drug registration granted by the Pharmaceutical and Herbal Medicine Registration and Control Administration ofthat certified its drug - Lianhua Qingwen capsules - as a herbal medicine to be registered in .
It's the first time thathas been granted permission in countries other than to treat symptoms caused by mild and moderate cases of COVID-19.
Lianhua Qingwen is the leading product of Yiling Pharmaceutical. Since the initial outbreak of COVID-19, it's been recommended in the Diagnosis and Treatment Protocol for COVID-19 (Version 4/5/6/7/8) released by national authorities and in the diagnosis and treatment protocols in over 20 provinces in the country.